Finding medication-caused problems when older adults arrive at the emergency department
Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments
This project uses a pharmacist checklist (AT HARM 10) to see if it can find medication-related harms in patients over 65 who come to the Hautepierre emergency department in Strasbourg.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 66 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT07333131 on ClinicalTrials.gov |
What this trial studies
This is an observational program in which clinical pharmacists apply the AT HARM 10 checklist to identify possible iatrogenic drug events among older adults presenting to the emergency department. Patients included are over 65, treated at the Hautepierre/CHU de Strasbourg emergency department, and have a Von Korff prioritization score above 7. The approach relies on a multidisciplinary team and an established detection tool that has been validated for use by pharmacists and pharmacy students. Data are used for clinical pharmacy activity to adapt treatment and are included only for patients who have not objected to reuse of their records for research.
Who should consider this trial
Good fit: Ideal candidates are patients aged over 65 who present to the Hautepierre emergency department with a Von Korff score above 7 and who have not objected to reuse of their medical data.
Not a fit: Patients under 65, people treated outside the participating emergency department, or those who have opted out of data reuse are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the work could help emergency teams detect medication-related admissions sooner and guide changes that reduce harmful readmissions.
How similar studies have performed: The AT HARM 10 checklist has been validated for use by pharmacists and pharmacy students, though evidence of broad impact on readmission rates is still limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient (\> 65 years old) * Treated in the emergency department of Hautepierre Hospital * Presenting a prioritization score \> 7 according to the Von Korff score * Subject (and their legal representative, if applicable) not objecting to the reuse of their data for scientific research purposes. Exclusion Criteria: \- Presence of a written objection in the patient's medical file (and/or that of their legal representative, if applicable) to the reuse of their data for scientific research purposes
Where this trial is running
Strasbourg
- Service de Pharmacie - Stérilisation - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Julia WALTHER, PharmD
- Email: julia.walther@chru-strasbourg.fr
- Phone: 33 3 88 12 78 18
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.